Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > CONTESSA PHARMA
View:
Post by Jkj193741 on Feb 16, 2021 1:37pm

CONTESSA PHARMA

MONCEF SLAOUI's NEW GIG. GV , BEAR, OR ANYONE, CHECK IT OUT AND SEE IF ZENITH COULD BE A POTENTIAL PLAYER. EXCITING IDEA. Thx jk
Comment by Jkj193741 on Feb 17, 2021 3:20pm
Could we get some big bucks from THES folks, anyone? https://www.thepharmaletter.com/article/new-pharma-r-d-model-ten-becomes-one-called-centessa
Comment by Jkj193741 on Feb 17, 2021 8:56pm
https://www.cityam.com/centessa-launches-with-250m-funding-in-bid-to-take-on-big-pharma/
Comment by G1945V on Feb 18, 2021 10:07am
JK, don't know what to make of this Contessa concept. How do they prioritize???   Don't know what to make of where Don is heading also with this go-it-alone approach. We keep saying that but really when relying on new funds to come on board for BOM2, Don would be looking at a new partner or partners so can't really equate that as go-it-alone. We need Eastern and ORI to inject ...more  
Comment by narmac on Feb 18, 2021 11:14am
,,,,Hear ye hear ye,,,blockbuster junior biotech shares going for .89 cents CAD,,,,believe that if you will....,,isnt this just pitiable,,,shame on this inept management team from the top down,,,,this company continues to be nothing short of a gd ballbuster,,,,,and thats the best this team can produce after spending ruffly $500 milliion in research funding??,,,,,its a big GOOD GRIEF CHARLIE BROWN ...more  
Comment by Jkj193741 on Feb 18, 2021 7:36pm
BEST OF CLASS IN BIO, GV. THEY HAVE 250 MILLION TO INVEST. SENT INFO TO SARAH. WOULD THINK RVX WOULD BE A NATURAL FOR THEM ? INTERESTING CONCEPT. THX, JK
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities